Janus Henderson Group PLC Takes Position in Clover Health Investments, Corp. (NASDAQ:CLOV)

Janus Henderson Group PLC acquired a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 169,300 shares of the company's stock, valued at approximately $477,000.

Several other institutional investors have also modified their holdings of CLOV. HighTower Advisors LLC acquired a new position in Clover Health Investments in the 3rd quarter valued at about $97,000. Verition Fund Management LLC purchased a new stake in shares of Clover Health Investments in the 3rd quarter valued at approximately $411,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Clover Health Investments in the 3rd quarter valued at approximately $1,228,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Clover Health Investments in the 3rd quarter valued at approximately $271,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Clover Health Investments by 5.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,000,505 shares of the company's stock valued at $8,461,000 after buying an additional 150,550 shares in the last quarter. Institutional investors and hedge funds own 19.77% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, UBS Group began coverage on shares of Clover Health Investments in a research note on Monday, October 7th. They set a "neutral" rating and a $4.00 price target for the company.

Clover Health Investments Stock Performance

Clover Health Investments stock traded up $0.01 during trading hours on Monday, reaching $3.12. 4,464,974 shares of the stock were exchanged, compared to its average volume of 7,776,695. The firm's 50 day moving average is $3.65 and its 200 day moving average is $2.62. The stock has a market cap of $1.56 billion, a P/E ratio of -15.55 and a beta of 1.94. Clover Health Investments, Corp. has a 52-week low of $0.61 and a 52-week high of $4.71.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.01. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. The business had revenue of $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. During the same quarter last year, the firm posted ($0.09) EPS. Equities research analysts expect that Clover Health Investments, Corp. will post -0.12 EPS for the current fiscal year.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.